Publications
Study investigated the pharmacokinetics, safety, and effects of riluzole, a sodium-channel blocking medication, on neurological outcome in acute spinal cord injury (SCI). Thirty-six patients (28 cervical and 8 thoracic), enrolled at 6 North American Clinical Trials Network (NACTN) sites, received 50 milligrams of riluzole twice daily, within 12 hours of ...